Skip to main content

Table 5 Results of ALK testing in selected centers in 2014a

From: NSCLC molecular testing in Central and Eastern European countries

 

ALK, n (%)

Non-diagnostic

 

WT

Rearrangement

Croatia

161 (93.1)

12 (6.9)

28

Czech (Prague)

55 (96.5)

2 (3.5)

10

Czech (Hradec Kralove)

260 (95.2)

13 (4.8)

2

Hungary (Budapest, Timár)

332 (94.9)

18 (5.1)

0

Hungary (Budapest, Toth)

122 (98.4)

2 (1.6)

4

Hungary (Budapest, Kovalszky)

415 (95.6)

19 (4.4)

0

Hungary (Debrecen)

226 (91.5)

21 (8.5)

35

Hungary (Pécs)

55 (94.8)

3 (5.2)

2

Slovakia

375 (88)

51 (12)

0

Slovenia

199 (96.5)

7 (3.5)

0

Turkey (Cerrahpaşa)

764 (95.6)

35 (4.4)

14

  1. ALK anaplastic lymphoma kinase, WT wild-type
  2. aNote that these numbers cannot be compared directly because of the different criteria for selection of samples to test; in some centers only samples negative for KRAS and EGFR mutations were tested for ALK translocations